SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-015381
Filing Date
2024-05-08
Accepted
2024-05-08 16:34:31
Documents
62
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q dmtp20240331_10q.htm   iXBRL 10-Q 669014
2 EXHIBIT 31.1 ex_666023.htm EX-31.1 13717
3 EXHIBIT 31.2 ex_666024.htm EX-31.2 12720
4 EXHIBIT 32.1 ex_666025.htm EX-32.1 4800
5 EXHIBIT 32.2 ex_666026.htm EX-32.2 5040
11 image01.jpg GRAPHIC 46287
  Complete submission text file 0001437749-24-015381.txt   3858276

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA dmac-20240331.xsd EX-101.SCH 39252
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dmac-20240331_def.xml EX-101.DEF 253615
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE dmac-20240331_lab.xml EX-101.LAB 213511
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dmac-20240331_pre.xml EX-101.PRE 279336
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dmac-20240331_cal.xml EX-101.CAL 31159
66 EXTRACTED XBRL INSTANCE DOCUMENT dmtp20240331_10q_htm.xml XML 492720
Mailing Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305
Business Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305 (763) 496-5454
DiaMedica Therapeutics Inc. (Filer) CIK: 0001401040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36291 | Film No.: 24926798
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)